ScholarIQanswers from OpenAlex
Felix Platter-Hospital
InstitutionResearch output, impact & collaborations
Felix Platter-Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Felix Platter-Hospital?
ScholarIQrecord summary
Felix Platter-Hospital is a research organisation in Basel, CH. OpenAlex records 1,250 works and 93,775 citations for it. 297 researchers list it as their most recent affiliation.
How many works does Felix Platter-Hospital have?
ScholarIQindexed works
Felix Platter-Hospital has 1,250 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Felix Platter-Hospital have?
ScholarIQcitation count
Felix Platter-Hospital has 93,775 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Felix Platter-Hospital?
ScholarIQresearcher count
Felix Platter-Hospital has 297 researchers in the ScholarIQ index.
What is the average h-index at Felix Platter-Hospital?
ScholarIQavg h-index
Felix Platter-Hospital has an average h-index of 95 in OpenAlex.
What is the ROR of Felix Platter-Hospital?
ScholarIQror
The ROR for Felix Platter-Hospital is on the source record.
What is the OpenAlex record for Felix Platter-Hospital?
ScholarIQopenalex
The OpenAlex for Felix Platter-Hospital is on the source record.
Who are the most-cited researchers behind Felix Platter-Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Felix Platter-Hospital?
ScholarIQmost cited works
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Johannes F.E. Mann, John J.V. McMurray, Magnus Lindberg, Peter Rossing, C. David Sjöström, Roberto D. Toto, Anna-Maria Langkilde, David C. Wheeler
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
Andrew S. Levey, R. C. Atkins, Josef Coresh, Eric P. Cohen, A.J. Collins, Kai‐Uwe Eckardt, Meguid El Nahas, Bertrand L. Jaber, Michel Jadoul, Adeera Levin, Neil R. Powe, Jérôme Rossert, David C. Wheeler, Norbert Lameire, Garabed Eknoyan
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
Colin Baigent, Jonathan Emberson, Richard Haynes, William G. Herrington, Parminder K. Judge, Martin Landray, Kaitlin J. Mayne, Sarah Y A Ng, David Preiss, Alistair Roddick, Natalie Staplin, Doreen Zhu, Stefan D. Anker, Deepak L. Bhatt, Martina Brueckmann, Javed Butler, David Z.I. Cherney, Jennifer B. Green, Sibylle J. Hauske, Richard Haynes, Hiddo J.L. Heerspink, William G. Herrington, Silvio E. Inzucchi, Meg Jardine, Chih‐Chin Liu, Kenneth W. Mahaffey, Finnian R. McCausland, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Brendon L. Neuen, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faı̈ez Zannad
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Brendon L. Neuen, T. Kue Young, Hiddo J.L. Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W. Mahaffey, David M. Charytan, David C. Wheeler, Clare Arnott, Séverine Bompoint, Adeera Levin, Meg Jardine
How much of the research on Felix Platter-Hospital is open access?
ScholarIQopen access share
92%OPEN ACCESS